Replies to post #216770 on Avid Bioservices Inc (CDMO)

[JCNJ]

2 points on Opdivo v Bavi

1. Just yesterday, someone posted or I read that a big pharma just initiated a phase III trial in NSCLC using docetaxol as the MOS. To me that is a good sign, Doce is still the SOC

2. That we are even talking about Opdivo makes me even more sickened by the CSM situation. Bavi should have been approved/helping people and shareholders > 2 years ago!!

all imo good luck longs

[EYEBUYSTOX]

10 months MOS means nothing! Throwing out 10 months as if it means something when it's not in the context of a comparison against the control is a pointless exercise. Remember what happened to our front line trial? And what did it do to the stock price after the "record breaking" 14 month MOS?